Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients
(1) Background: Precision oncology is opening new treatment opportunities for patients suffering from solid tumors. In the last two decades, the advent of CDK4/6 inhibitors, immunotherapy, and antibody–drug conjugates (ADC) improved survival outcomes for advanced or metastatic breast cancers (BC). N...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2023-02-01
|
| Schriftenreihe: | Current Oncology |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/1718-7729/30/2/191 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
